Do you want to read an article? Please log in or register.
Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice
Multiple Sclerosis
RECOMMENDED
Related content
RECOMMENDED
Multiple Sclerosis
SwissTecLive: effectiveness and safety of dimethyl fumarate in the treatment of RRMS in the Swiss clinical practice setting
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Heliyon
Zecca C, Czaplinski A, Henny C, Petrini L, Beeler A, Gobbi C
doi: 10.1016/j.heliyon.2020.e05819
RECOMMENDED
Multiple Sclerosis
Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study
Neurology.
Buron MD, Chalmer TA, Sellebjerg F, Frederiksen J, Góra MK, Illes Z, Kant M, Mezei Z, Petersen T, Rasmussen PV, Roshanisefat H, Hassanpour-Kalam-Roudy H, Sejbæk T, Tsakiri A, Weglewski A, Sorensen PS, Magyari M
doi: 10.1212/WNL.
Multiple Sclerosis
Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies
Eur J Neurol.
Havrdova E, Giovannoni G, Gold R, Fox RJ, Kappos L, Phillips JT, Okwuokenye M, Marantz JL
doi: 10.1111/ene.13272.
Multiple Sclerosis
Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis
J Autoimmun.
Diebold M, Sievers C, Bantug G, Sanderson N, Kappos L, Kuhle J, Lindberg RLP, Derfuss T
doi: 10.1016/j.jaut.2017.09.009.
Multiple Sclerosis
Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study
Neurology.
Prosperini L, Lucchini M, Haggiag S, Bellantonio P, Bianco A, Buscarinu MC, Buttari F, Centonze D, Cortese A, De Giglio L, Fantozzi R, Ferraro E, Fornasiero A, Francia A, Galgani S, Gasperini C, Marfia GA, Millefiorini E, Nociti V, Pontecorvo S, Pozzilli C, Ruggieri S, Salvetti M, Sgarlata E, Mirabella M
doi: 10.1212/WNL.
Multiple Sclerosis
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis
J Neurol Neurosurg Psychiatry.
Kalincik T, Kubala Havrdova E, Horakova D, Izquierdo G, Prat A, Girard M, Duquette P, Grammond P, Onofrj M, Lugaresi A, Ozakbas S, Kappos L, Kuhle J, Terzi M, Lechner-Scott J, Boz C, Grand'Maison F, Prevost J, Sola P, Ferraro D, Granella F, Trojano M, Bergamaschi R, Pucci E, Turkoglu R, McCombe PA, Pesch VV, Van Wijmeersch B, Solaro C, Ramo-Tello C, Slee M, Alroughani R, Yamout B, Shaygannejad V, Spitaleri D, Sánchez-Menoyo JL, Ampapa R, Hodgkinson S, Karabudak R, Butler E, Vucic S, Jokubaitis V, Spelman T, Butzkueven H
doi: 10.1136/jnnp-2018-319831.
Aging and Cognitive FunctionsPsychosis and Schizophrenia
Placebo Response and Practice Effects in Schizophrenia Cognition Trials
JAMA Psychiatry.
Keefe RSE, Davis VG, Harvey PD, Atkins AS, Haig GM, Hagino O, Marder S, Hilt DC, Umbricht D
doi: 10.1001/
SPECIAL REPORT
Multiple Sclerosis
Vaccination Readiness in Multiple Sclerosis
RECOMMENDED
Multiple Sclerosis
Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Neurol Neuroimmunol Neuroinflamm.
Diem L, Daponte A, Findling O, Miclea A, Briner M, Salmen A, Gold R, Kilidireas C, Chan A, Evangelopoulos ME, Hoepner R
doi: 10.1212/NXI.0000000000000660.